A new study published in the Journal of Clinical Oncology reveals that marijuana capsules containing both tetrahydrocannabinol (THC) and cannabidiol (CBD) significantly reduces chemotherapy-induced nausea and vomiting in patients who have not responded to standard antiemetic treatments.

Marijuana capsules.
This randomized, placebo-controlled, phase II/III trial, conducted across 19 hospitals and universities in Australia, is one of the most comprehensive studies to date on the subject.
The study aimed to assess the efficacy of THC capsules as an adjunct treatment for adults suffering from nausea and vomiting during moderately or highly emetogenic chemotherapy, despite receiving guideline-consistent antiemetic prophylaxis. The trial included 147 participants who were given either the THC capsules or a placebo, in addition to their standard antiemetic medication during the first cycle of chemotherapy.
Continue reading